BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19935427)

  • 1. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.
    Beckie TM; Beckstead JW; Groer MW
    J Cardiovasc Nurs; 2010; 25(1):52-60. PubMed ID: 19935427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial.
    Beckie TM; Beckstead JW; Schocken DD; Evans ME; Fletcher GF
    Int J Nurs Stud; 2011 Jan; 48(1):3-12. PubMed ID: 20615504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity interval training improves metabolic syndrome and body composition in outpatient cardiac rehabilitation patients with myocardial infarction.
    Dun Y; Thomas RJ; Smith JR; Medina-Inojosa JR; Squires RW; Bonikowske AR; Huang H; Liu S; Olson TP
    Cardiovasc Diabetol; 2019 Aug; 18(1):104. PubMed ID: 31412869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting cardiac rehabilitation attendance in a gender-tailored randomized clinical trial.
    Beckie TM; Beckstead JW
    J Cardiopulm Rehabil Prev; 2010; 30(3):147-56. PubMed ID: 20216324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance training reduces metabolic syndrome and inflammatory markers in older women: A randomized controlled trial.
    Tomeleri CM; Souza MF; Burini RC; Cavaglieri CR; Ribeiro AS; Antunes M; Nunes JP; Venturini D; Barbosa DS; Sardinha LB; Cyrino ES
    J Diabetes; 2018 Apr; 10(4):328-337. PubMed ID: 29031002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of carbohydrate versus fat restriction on serum levels of adipocytokines, markers of inflammation, and endothelial function among women with the metabolic syndrome: a randomized cross-over clinical trial.
    Rajaie S; Azadbakht L; Saneei P; Khazaei M; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):159-67. PubMed ID: 24021709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults.
    Van Guilder GP; Hoetzer GL; Greiner JJ; Stauffer BL; Desouza CA
    Obesity (Silver Spring); 2006 Dec; 14(12):2127-31. PubMed ID: 17189537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Tehranian population: the Tehran Lipid and Glucose Study.
    Zarkesh M; Faam B; Daneshpour MS; Azizi F; Hedayati M
    Intern Med; 2012; 51(24):3329-35. PubMed ID: 23257516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes.
    Laddu DR; Ozemek C; Hauer TL; Rouleau CR; Campbell TS; Wilton SB; Aggarwal S; Austford L; Arena R
    Int J Cardiol; 2020 Feb; 301():156-162. PubMed ID: 31806276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors.
    Kajikawa Y; Ikeda M; Takemoto S; Tomoda J; Ohmaru N; Kusachi S
    Int Heart J; 2011; 52(1):17-22. PubMed ID: 21321463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fat load effects on inflammation and endothelial stress markers in healthy subjects.
    Derosa G; Ferrari I; D'Angelo A; Salvadeo SA; Fogari E; Gravina A; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    Heart Vessels; 2009 May; 24(3):204-10. PubMed ID: 19466522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
    Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
    Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients.
    Ades PA; Savage PD; Toth MJ; Harvey-Berino J; Schneider DJ; Bunn JY; Audelin MC; Ludlow M
    Circulation; 2009 May; 119(20):2671-8. PubMed ID: 19433757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects.
    Möller K; Ostermann AI; Rund K; Thoms S; Blume C; Stahl F; Hahn A; Schebb NH; Schuchardt JP
    Prostaglandins Leukot Essent Fatty Acids; 2016 Mar; 106():39-49. PubMed ID: 26751601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Mediterranean diet on inflammatory biomarkers and components of metabolic syndrome in adolescent girls.
    Asoudeh F; Fallah M; Aminianfar A; Djafarian K; Shirzad N; Clark CCT; Larijani B; Esmaillzadeh A
    J Endocrinol Invest; 2023 Oct; 46(10):1995-2004. PubMed ID: 36795242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective association between the dietary inflammatory index and metabolic syndrome: findings from the SU.VI.MAX study.
    Neufcourt L; Assmann KE; Fezeu LK; Touvier M; Graffouillère L; Shivappa N; Hébert JR; Wirth MD; Hercberg S; Galan P; Julia C; Kesse-Guyot E
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):988-96. PubMed ID: 26482566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
    Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of cardiac rehabilitation and exercise after percutaneous coronary intervention on hsCRP and inflammatory cytokines in CAD patients.
    Kim YJ; Shin YO; Bae JS; Lee JB; Ham JH; Son YJ; Kim JK; Kim C; Lee BK; Oh JK; Othman T; Min YK; Yang HM
    Pflugers Arch; 2008 Mar; 455(6):1081-8. PubMed ID: 17906875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
    Dieli-Conwright CM; Wong L; Waliany S; Bernstein L; Salehian B; Mortimer JE
    Cancer; 2016 Sep; 122(17):2646-53. PubMed ID: 27219902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.